Date | Title | Description | |
---|---|---|---|
22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
29 Apr 2021 | On business and financial situation | The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States. | Download |
12 Apr 2021 | On business and financial situation | The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. | Download |
02 Mar 2021 | On business and financial situation | The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
02 Mar 2021 | On business and financial situation | The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
Pages
Date | Title | Description | |
---|---|---|---|
01 Aug 2024 | Other relevant information | The Company has agreed to execute the share capital reduction approved by the 2024 Ordinary General Meeting to amortize treasury shares, among which those acquired in the framework of the own shares repurchase program. | Download |
31 Jul 2024 | Liquidity and counterparty agreements | Modification of securities and cash balances associated with the Liquidity Contract signed between the Company and Bestinver, S.V., S.A. | Download |
08 Jul 2024 | Other relevant information | The Company informs about the dividends payment. | Download |
04 Jul 2024 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the second quarter of 2024 | Download |
24 Jun 2024 | Announcement of General Shareholders' Meeting | The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
20 Feb 2018 | Información sobre resultados | ROVI releases the presentation related to the full year 2017 results | Download |
20 Feb 2018 | Información sobre resultados | ROVI releases the press release related to the full year 2017 results | Download |
20 Feb 2018 | Informe anual de remuneraciones de los consejeros | ROVI releases the 2017 annual report regarding remuneration of the members of the Board of Directors | Download |
20 Feb 2018 | Informe Anual de Gobierno Corporativo | ROVI releases the 2017 Annual Corporate Governance Report | Download |
20 Feb 2018 | Otros sobre gobierno corporativo | The Company informs about the agreements adopted by the Board of Directors | Download |